This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit
Hybrid Event, 20 - 24 June 2022
In-Person: Clayton Hotel Burlington Road, Dublin, IrelandDigital Experience: One track will be live-streamed each day in BST time zone, with on-demand recording access for all other tracks made available from Monday 27th June. Learn more on the Digital Experience page.

Camilla Fleetcroft
EX MHRA - Deputy Director of Innovative Devices, Eclevar UK VP clinical and regulatory at ECLEVAR UK

Profile

Camilla has a wealth of experience in both clinical and regulatory spaces. Since qualifying as a doctor, she has been working at the MHRA for over 8 years, with a short time spent at SGS. In her role, as Deputy Director for Innovative Devices, she led the development of the future UK regulations for medical devices following Brexit, and is involved with policy makers, regularly interacting with ministers and decision makers.

Prior to that Camilla was the Head of Clinical Investigations and Evaluation at MHRA and before the UK exit from the EU, she represented the MHRA in the EU Clinical Investigations and Evalution working group, leading the drafting for MDCG 2020-05 on Equivalence and working on the practicalities & challenges of the implementation for the MDR requirements for CIs and Clinical Evalution in the UK.

Agenda Sessions

  • A Regulators Perspective on Clinical Evaluations and Investigations

    09:10